Anteris Technologies Global (AVR) vs Cadre (CDRE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anteris Technologies Global (AVR) has outperformed Cadre (CDRE) over the past year, gaining 38.4% versus a loss of 35.6%. Cadre is the larger company by market cap ($1.05 billion vs $659.8 million), about 1.6 times the size. Cadre pays a dividend yielding 1.59%, while Anteris Technologies Global does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVR | CDRE |
|---|---|---|
| Share price | $6.77 | $24.55 |
| Market cap | $659.79M | $1.05B |
| 1-day change | +2.11% | -1.13% |
| YTD return | +35.67% | -39.20% |
| 1-year return | +38.45% | -35.61% |
| P/E ratio (TTM) | — | 30.69 |
| Forward P/E | — | 14.96 |
| EPS (TTM) | $-1.95 | $0.80 |
| Dividend yield | 0.00% | 1.59% |
| Annual dividend | $0.00 | $0.39 |
| 52-week high | $11.06 | $48.76 |
| 52-week low | $3.30 | $24.07 |
| Distance from 52-week high | -38.76% | -49.65% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +106.79% | +93.48% |
| Average volume | 938.88K | 418.04K |
| Shares outstanding | 97.46M | 42.82M |
| Employees | 174 | 2,533 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AVR has outperformed CDRE by 74.1 percentage points over the past year.
- Cadre offers a meaningfully higher dividend yield (1.59% vs 0.00%).
About Anteris Technologies Global
AVR stock →Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve.
Health Care · Industrial Specialties · 174 employees
About Cadre
CDRE stock →Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally.
Health Care · Industrial Specialties · 2,533 employees
AVR vs CDRE FAQ
Which is bigger, Anteris Technologies Global or Cadre?
Cadre (CDRE) is larger, with a market capitalization of $1.05B compared with $659.79M for Anteris Technologies Global (AVR).
Which stock has performed better over the past year, AVR or CDRE?
AVR returned +38.45% over the past 12 months, compared with -35.61% for CDRE (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Anteris Technologies Global or Cadre?
Cadre pays a dividend yielding 1.59%, while Anteris Technologies Global does not currently pay a regular dividend.
Are Anteris Technologies Global and Cadre in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.